Video Experimental Relacionado
Updated: Jun 10, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
¿Es hora de que los oncólogos opten por las pruebas de rutina de exclusión voluntaria del VIH?
Elizabeth Y Chiao1, Bruce J Dezube, Susan E Krown
1Department of Medicine, Baylor College of Medicine, and Health Services Research and Development, Department of Veterans Affairs Medical Center, Houston, Texas 77030, USA. echiao@bcm.edu
JAMA
|July 20, 2010
Resumen
Se recomienda la prueba de rutina de exclusión voluntaria del virus de la inmunodeficiencia humana (VIH) para pacientes con cáncer. Este enfoque puede mejorar los resultados al permitir el manejo oportuno del VIH durante el tratamiento del cáncer para las personas diagnosticadas.
Área de la Ciencia:
- Oncología Oncología.
- Enfermedades infecciosas Enfermedades infecciosas.
- Salud Pública La salud pública.
Sus antecedentes:
- Las personas con el virus de la inmunodeficiencia humana (VIH) tienen un mayor riesgo de desarrollar tumores malignos.
- Las pruebas rutinarias de VIH no son la atención estándar para los pacientes con cáncer, a pesar de las recomendaciones de los CDC para la detección de exclusión voluntaria en todos los entornos de atención médica.
- Las actuales pruebas de exclusión voluntaria del VIH se dirigen principalmente a poblaciones específicas, con una implementación limitada en entornos clínicos más amplios como la oncología.
Objetivo del estudio:
- Presentar el fundamento lógico y la evidencia que apoya las pruebas de rutina de exclusión voluntaria del VIH para pacientes con cáncer.
- Discutir el potencial de las pruebas de exclusión voluntaria del VIH para mejorar los resultados clínicos a través de una mejor gestión del VIH durante el tratamiento del cáncer.
Principales métodos:
- Revisión de antecedentes, justificación y evidencia de apoyo para la exclusión voluntaria de las pruebas de VIH en pacientes con cáncer.
- Discusión de la evidencia para mejorar los resultados clínicos a través del manejo facilitado del VIH.
Principales resultados:
- Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) corren un alto riesgo de desarrollar neoplasias malignas.
- La prueba de VIH de exclusión voluntaria de rutina no se implementa ampliamente en los Estados Unidos, a pesar de las recomendaciones.
- Las pruebas de exclusión voluntaria han demostrado potencial en entornos específicos, pero requieren una aplicación más amplia.
Conclusiones:
- Las pruebas de rutina de exclusión voluntaria del VIH deben considerarse la atención estándar para los pacientes con cáncer.
- La implementación de pruebas de exclusión voluntaria del VIH puede conducir a un mejor manejo del VIH durante el tratamiento del cáncer.
- Esta estrategia tiene el potencial de mejorar significativamente los resultados clínicos de los pacientes con cáncer VIH-positivos.
Videos de Conceptos Relacionados
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...